from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3588c/canB

LFCtreatmentdescriptionclass of inhibitor

-1.368

Amikacinug/mL Amikacintranslation

-1.227

Cap5-10ug/mL Capreomycintranslation

-1.908

Rox10-50 ug/mL Roxithromycintranslation

-0.678

SM2-5 ug/mL Streptomycintranslation

-2.953

Tet5-10 ug/mL Tetracyclinetranslation

-0.616

Rif0.2-5ug/mL Rifampicintranscription

-1.047

Rifp0.1-0.5ug/mL Rifapentinetranscription

3.318

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.563

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.539

CPZ10-50 ug/mL Chlorpromazinerespiration

0.839

Clofazimine10-13 ug/mL Clofaziminerespiration

0.283

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.126

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.014

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.662

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.662

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.318

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.002

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.261

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.142

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.595

KCN5-20 ug/mL Potassium cyaniderespiration

0.041

NaN30.2-2 mM Sodium aziderespiration

-0.227

Nigericin50 uM Nigericinrespiration

-0.810

TRC10-150 ug/mL Triclosanrespiration

0.416

TRZ10-25 ug/mL Thioridazinerespiration

-1.135

Valinomycin0.5-10 uM Valinomycinrespiration

-0.045

ZnSO42 mM ZnSO4respiration

0.637

menadione6-10 ug/mL Menadionerespiration

0.655

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.007

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.346

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.155

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.420

NRP_1Non-replicating persistence stage 1dosRassociated

0.383

Amp0.2mg/mL AmpicillincellWall

-0.112

Cephalexin20-100 ug/mL CephalexincellWall

0.091

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.207

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.124

EMB10-20 ug/mL EthambutolcellWall

0.029

Eta12-40 ug/mL EthionamidecellWall

0.031

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.065

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.984

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.718

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.367

BZA0.12 mg/mL BenzamidearomaticAmides

-0.127

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.543

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.319

H2O24 mM hydrogen peroxideDNAdamaging

-0.599

Levo10 ug/mL LevofloxacinDNAdamaging

-0.089

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.793

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.576

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.206

UVUV-irradiationDNAdamaging

0.638

ARP41-4 ug/mL Antitubercular compound ARP4?

0.000

Antimycin12.5-50 ug/mL Antimycin A?

0.173

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.216

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.284

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.733

PA8240.2-2 ug/mL PA-824?

-0.710

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.155

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.978

Verapamil50 uM Verapamil?

0.333

mercaptoethanol2 mM 2-Mercaptoethanol?

0.442

methoxatin10-20 ug/mL Methoxatin?